Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial
Crossref DOI link: https://doi.org/10.1186/s13063-016-1466-2
Published Online: 2016-07-25
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
van Schaik, Ivo N.
,
van Geloven, Nan
Bril, Vera
Hartung, Hans-Peter
Lewis, Richard A.
Sobue, Gen
Lawo, John-Philip
Mielke, Orell
Cornblath, David R.
Merkies, Ingemar S. J.
Funding for this research was provided by:
CSL Behring